Description
KGDS is a synthetic peptide derived from fibrinogen. KGDS activates the glycoprotein IIb/IIIa receptor, inhibiting fibrinogen-platelet binding and thrombin activity.
KGDS is a synthetic peptide derived from fibrinogen. KGDS activates the glycoprotein IIb/IIIa receptor, inhibiting fibrinogen-platelet binding and thrombin activity.
| Purity | ≥95% |
|---|---|
| Formula | C15H27N5O8 |
| Formula Wt. | 405.41 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Knapp A, Degenhardt T, Dodt J. Hirudisins. Hirudin-derived thrombin inhibitors with disintegrin activity. J Biol Chem. 1992 Dec 5;267(34):24230-4. PMID: 1447173.
Parise LV, Helgerson SL, Steiner B, et al. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa. J Biol Chem. 1987 Sep 15;262(26):12597-602. PMID: 2957377.
EGFR2 inhibitor.
PDK1 and Akt inhibitor.
Thalidomide derivative; cereblon and TNF-α inh...
Flavone found in Teucrium.
Phase II enzyme inducer; Nrf2 activator; antiox...
Prenylated phenolic terpene found in various pl...
Lck, Src, SIK inhibitor.
Resveratrol prodrug; potential SIRT1 activator....
Alkaloid found in Corydalis; D1 antagonist, org...
ACE inhibitor.
Produced by Aspergillus; type 2 methionine amin...
Synthesis impurity
Fluorouracil impurity
Cysteine-ITC conjugate, antioxidant; aldehyde d...
Zika Virus antigen
Mycotoxin produced by Penicillum and Aspergillu...
Venlafaxine metabolite; SERT and NET inhibitor....
GSK-3β, HGK, and CDK inhibitor.
NSAID; COX-1/2 and lipoxygenase inhibitor.